Nicardipine via spine tube for brain blood vessel spasm
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether giving a medicine called nicardipine through a tube in the spine (intrathecal) helps prevent or treat blood vessel tightening that can happen after a brain aneurysm rupture. It is for people who have had a specific type of brain bleed and show signs of vessel spasm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had bleeding around the brain from a sac-like aneurysm, and the aneurysm has been fixed with surgery or a catheter.
- You have a drain in your spine or brain to remove bloody fluid, or doctors placed one to manage fluid buildup.
- Doctors suspect blood vessel tightening (vasospasm) based on tests like ultrasound, CT, MRI, or symptoms like confusion or weakness.
- It has been less than 14 days since the bleeding started.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a spinal fluid (CSF) treatment to help prevent dangerous blood-vessel tightening (vasospasm) after a type of brain bleed caused by an aneurysm. If you qualify, the goal is to reduce complications soon after aneurysm repair.
This trial tests whether adding cilostazol to standard nimodipine treatment helps people recover better after a brain aneurysm bursts. Both drugs aim to prevent delayed complications from the bleeding.
This trial tests if a nerve stimulation device can prevent a dangerous blood vessel spasm after a brain aneurysm bleed. It may help reduce damage and improve recovery.
This study examines whether a substance called nitric oxide in brain fluid can help doctors predict who will develop dangerous blood vessel tightening after a subarachnoid hemorrhage—a serious type of brain bleeding. The goal is to find an early warning sign so doctors can intervene faster.
This study tests whether nadroparine (a blood-thinning medicine) can improve outcomes after a type of brain bleed called subarachnoid hemorrhage. It focuses on people who have had a brain aneurysm treated with a procedure soon after the bleed.
This Phase 2 trial tests whether milrinone, a heart-acting medicine, can improve brain blood flow to help prevent delayed brain ischemia after a severe subarachnoid hemorrhage. It may help reduce later brain damage in people who are too ill or sedated for a normal neurologic exam early on.
Hear when a new Aneurysmal Subarachnoid Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.